Resveratrol potentiates chemotherapeutic efficacy of olaparib in MCF7 human breast cancer cells by inducing apoptosis

  • Ir J Med Sci. 2026 Jan 10. doi: 10.1007/s11845-025-04240-8.
Mehmet Kadir Erdoğan  1  2  3 ,  Ramazan Gundogdu  4  5  6 ,  Yusuf Toy  7 ,  Esra Polat  7 ,  Can Ali Agca  8 ,  Aydın Sever  7 ,  Burak Tüzün  9
Affiliations
  • 1. Department of Molecular Biology and Genetics, Bingol University, 12000, Bingol, Türkiye. [email protected].
  • 2. Department of Biology, Institute of Science, Bingol University, 12000, Bingol, Türkiye. [email protected].
  • 3. Department of Molecular Biology and Genetics, Institute of Science, Bingol University, Bingol, 12000, Türkiye. [email protected].
  • 4. Department of Pharmacy Services, Vocational School of Health Services, Bingol University, 12000, Bingol, Türkiye. [email protected].
  • 5. Department of Biology, Institute of Science, Bingol University, 12000, Bingol, Türkiye. [email protected].
  • 6. Department of Molecular Biology and Genetics, Institute of Science, Bingol University, Bingol, 12000, Türkiye. [email protected].
  • 7. Department of Biology, Institute of Science, Bingol University, 12000, Bingol, Türkiye.
  • 8. Department of Molecular Biology and Genetics, Bingol University, 12000, Bingol, Türkiye.
  • 9. Plant and Animal Production Department, Technical Sciences Vocational School of Sivas, Sivas Cumhuriyet University, Sivas, 58140, Türkiye.
PMID: 41518560 DOI: 10.1007/s11845-025-04240-8
Keywords
MCF7; PARP inhibition; Personalised medicine; Resveratrol.
Products